The Netherlands
Genematics Scientific is a biotech startup founded in 2016, addressing critical challenges in healthcare costs, food scarcity, and antibiotic resistance. The company has recognized the immense potential of big data in biology and aims to leverage it for impactful solutions. Specializing in Big Data, Biotechnology, and Clean Energy, Genematics is positioned to make significant contributions to global research efforts.
The company's approach involves creating an accessible platform for researchers worldwide to tap into the extensive pool of biological data. By facilitating easy access to this valuable resource, Genematics aims to empower researchers to drive innovation and address the pressing issues of the 21st century.
As of now, there is no publicly disclosed information available regarding the company's headquarters, specific investors, or recent investment rounds. However, given the critical nature of the problems they are working to solve, Genematics presents a compelling opportunity for potential venture capital investment, with the potential for significant impact and returns.
